| 前收市價 | 6.90 |
| 開市 | 6.50 |
| 買盤 | 9.70 |
| 賣出價 | 10.50 |
| 拍板 | 17.50 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 6.50 - 6.90 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 1.09k |
Motley FoolThe Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
New data indicate that its cell therapy could soon find a larger market.
ZacksIovance (IOVA) Up 5% on Updated Data From Melanoma Study
Iovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its combination therapy achieved an objective response rate of 65% in frontline advanced melanoma.
Motley FoolBull Market Buys: 2 Growth Stocks to Own for the Long Run
These biotech stocks have just launched their first products.
